<DOC>
	<DOCNO>NCT02700165</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy non-invasive reduction subcutaneous fat submental submandibular area use Cryolipolysis .</brief_summary>
	<brief_title>Submandibular Submental Study</brief_title>
	<detailed_description />
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Inclusion Criteria Male female subject &gt; 22 year age &lt; 65 year age . Submental submandibular skin fold thickness &gt; 1cm ( measure caliper ) . No weight change exceed 5 % body weight precede month . Agreement maintain his/her weight ( i.e. , within 5 % ) make major change diet exercise routine course study . Subject sign write informed consent form . Exclusion Criteria Skin laxity neck chin area reduction submental submandibular fat may , opinion investigator , result unacceptable aesthetic result . Prominent platysmal band rest may interfere assessment submental fat Evidence cause enlargement submental area localize subcutaneous fat , swell lymph node ptotic submandibular gland . Significant enlargement anterior neck may prevent proper placement applicator e.g . enlarge thyroid gland . Treatment dermal filler , radiofrequency laser procedure , chemical peel neck chin area ( mandible ) within past 6 month . Botulinum toxin aesthetic drug injection within neck chin area ( mandible ) within past 6 month . History facial nerve paresis paralysis ( Bell 's palsy ) . History fat reduction procedure ( e.g. , liposuction , surgery , lipolytic agent , etc . ) implant adjacent area intend treatment . History prior neck surgery , prior surgery area intend treatment . Current dental infection . Known history cryoglobulinemia , cold urticaria , cold agglutinin disease paroxysmal cold hemoglobinuria . Known history Raynaud 's disease , know condition response cold exposure limit blood flow skin . History bleed disorder take medication investigator 's opinion may increase subject 's risk bruising . Currently take take diet pill weight control supplement within past month . Any dermatological condition , scar location treatment area may interfere treatment evaluation . Active implanted device pacemaker , defibrillator , drug delivery system . Pregnant intend become pregnant next 6 month . Lactating lactate past 6 month . Unable unwilling comply study requirement . Currently enrol clinical study unapproved investigational drug device . Any condition laboratory value would , professional opinion investigator , potentially affect subject 's response integrity data would pose unacceptable risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>